Emilio Sanseviero
Oncology R&D
Cambridge, ENG, United Kingdom
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Harnessing myeloid cell plasticity for cancer therapy.
Journal: Nature cancer
Published: October 30, 2025
Syntaphilin Regulates Neutrophil Migration in Cancer.
Journal: Cancer immunology research
Published: January 12, 2022
Myeloid-Derived Suppressor Cells: A Propitious Road to Clinic.
Journal: Cancer discovery
Published: June 15, 2021
Upregulation of C/EBPα Inhibits Suppressive Activity of Myeloid Cells and Potentiates Antitumor Response in Mice and Patients with Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 17, 2021
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity.
Journal: Nature reviews. Immunology
Published: December 14, 2020
Isolation and Phenotyping of Splenic Myeloid-Derived Suppressor Cells in Murine Cancer Models.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: November 25, 2020
Analysis of classical neutrophils and polymorphonuclear myeloid-derived suppressor cells in cancer patients and tumor-bearing mice.
Journal: The Journal of experimental medicine
Published: August 20, 2020
Immune suppressive activity of myeloid-derived suppressor cells in cancer requires inactivation of the type I interferon pathway.
Journal: Nature communications
Published: May 04, 2020
Myeloid-Derived Suppressor Cells Are a Major Source of Wnt5A in the Melanoma Microenvironment and Depend on Wnt5A for Full Suppressive Activity.
Journal: Cancer research
Published: April 14, 2020
A Novel Inhibitor of HSP70 Induces Mitochondrial Toxicity and Immune Cell Recruitment in Tumors.
Journal: Cancer research
Published: February 03, 2020
Last Updated: 09/26/2026